ECKERT & ZIEGLER BG 
By IBt Bebig Changes Its Name to Eckert & Ziegler BEBIG
June 29, 2011
Seneffe, Belgium, June 29, 2011, IBt Bebig (Reuters: IBTH.BR - Bloomberg: IBTB BB), a global leader in brachytherapy, announced today that it has changed its corporate name to Eckert & Ziegler BEBIG S.A.
As of July 1, 2011, the company will trade on the Euronext exchange under the new ticker symbol EZBG.
The name change was recommended and approved during the Extraordinary General Meeting held on June 6, 2011 in Seneffe.
The new name, Eckert & Ziegler BEBIG S.A., underlines the company's affiliation with the Eckert & Ziegler Group, one of the world's largest providers of isotope technology for medical, scientific, and industrial purposes. The Eckert & Ziegler Group has four business segments, Radiation Therapy, Radiopharmaceuticals, Isotope Products, and Environmental Services, all operated through its subsidiaries. With over 30 years' experience in the radiation therapy business, Eckert & Ziegler BEBIG S.A. will continue to drive the Group's leadership position.
"The vision behind the renaming has been to reinforce the fact that we are a part of a leading group with a well recognized name: Eckert & Ziegler. This supports our strategy of further worldwide expansion and our commitment to developing and providing medical devices and products to cure cancer and enhance the quality of life," said Dr. Edgar Löffler, Managing Director of Eckert & Ziegler BEBIG S.A.
Cancer represents a major public health threat the world over. Radiation therapy is already prescribed for half of all cancer cases, and trends point to increased use. In this context, Eckert & Ziegler has set near-term objectives of globalizing the business, accelerating innovation, strengthening its portfolio, and ensuring supply.
Relationships with current business partners and customers will be managed through the same channels as before. The website domain name will change to www.bebig.eu:
http://www.bebig.eu/. and all company email addresses will have the following format: firstname.lastname@bebig.eu:
mailto:firstname.lastname@bebig.eu, as of July 1, 2011.
About Eckert & Ziegler BEBIG
Contributing to saving lives!
Eckert & Ziegler BEBIG is a European-based group active in the medical device segment of the health care industry.
Eckert & Ziegler BEBIG's core business is the treatment of cancer using brachytherapy, a special form of radiation therapy.
Eckert & Ziegler BEBIG is a leader in brachytherapy in Europe. The company headquarters are in Belgium, with a production facility in Germany and subsidiaries throughout Europe and in India. In addition, Eckert & Ziegler BEBIG has a worldwide network of distributors and agents to support the international marketing of its product line.
The company's products and equipment are intended for use by oncologists, radiologists, urologists, and medical physicists.
Eckert & Ziegler BEBIG employs more than 150 people. The company has been listed on the Euronext stock exchange since April 1997.
Contact
Paul-Emmanuel Goethals
Investor Relations
Tel.: +32.64.520.808
Email: ir@bebig.eu:
mailto:ir@bebig.eu
Website: www.bebig.eu:
http://www.bebig.eu/
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: IBt Bebig via Thomson Reuters ONE
